Value of theophylline treatment in patients handicapped by chronic obstructive lung disease (Q36276399)

13 August 2017

Value of theophylline treatment in patients handicapped by chronic obstructive lung disease (English)

1 reference

chronic obstructive pulmonary disease

13 August 2017

0 references

1 reference

McKay SE

1

1 reference

13 August 2017

Howie CA

2

1 reference

13 August 2017

Thomson AH

3

1 reference

13 August 2017

Whiting B

4

1 reference

13 August 2017

Addis GJ

5

1 reference

13 August 2017

language of work or name

English

0 references

publication date

1 March 1993

1 reference

13 August 2017

1 reference

13 August 2017

48

1 reference

13 August 2017

3

1 reference

13 August 2017

227-232

1 reference

Combination of aminophylline (Phyllocontin Continus tablets) and salbutamol in the management of chronic obstructive airways disease

13 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=464358

Modelling theophylline response in individual patients with chronic bronchitis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=464358

Effect of oral salbutamol and slow-release aminophylline on exercise tolerance in chronic bronchitis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=464358

Sustained release oral aminophylline in patients with airflow obstruction

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=464358

How many blows really make an FEV1, FVC, or PEFR?

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=464358

Effect of attitudes and beliefs on exercise tolerance in chronic bronchitis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=464358

A self paced treadmill walking test for breathless patients

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=464358

A measure of quality of life for clinical trials in chronic lung disease

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=464358

Reproducibility of walking test results in chronic obstructive airways disease

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=464358

Dose response relation to oral theophylline in severe chronic obstructive airways disease

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=464358

The use of theophylline in 'irreversible' chronic obstructive pulmonary disease. An update

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=464358

A randomized, controlled trial of theophylline in patients with severe chronic obstructive pulmonary disease

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=464358

Theophylline in the management of airflow obstruction. 2. Difficult drugs to use, few clinical indications

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=464358

Theophylline in the management of airflow obstruction. 1. Much evidence suggests that theophylline is valuable

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=464358

Phosphodiesterase inhibitors: new opportunities for the treatment of asthma

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=464358

Plasma theophylline concentrations, six minute walking distances, and breathlessness in patients with chronic airflow obstruction

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=464358

OPT: a package of computer programs for parameter optimisation in clinical pharmacokinetics

29 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=464358

Effect of aminophylline on exercise performance in patients with irreversible airway obstruction

22 September 2018

1 reference

12 December 2020

Efficacy of inhaled metaproterenol and orally-administered theophylline in patients with chronic airflow obstruction

1 reference

12 December 2020

Bronchodilators in chronic air-flow limitation. Effects on airway function, exercise capacity, and quality of life

1 reference

12 December 2020

Dyspnea and diaphragmatic fatigue in patients with chronic obstructive pulmonary disease. Responses to theophylline

1 reference

12 December 2020

The relationship between pulmonary function and dyspnea in obstructive lung disease

1 reference

12 December 2020

Measuring functional status in chronic lung disease: conclusions from a randomized control trial

1 reference

12 December 2020

Twelve-minute walking test for assessing disability in chronic bronchitis

1 reference

12 December 2020

Treatment of chronic obstructive pulmonary disease with orally administered theophylline. A double-blind, controlled study

1 reference

12 December 2020

A controlled study of slow-release theophylline and aminophylline in patients with chronic bronchitis

1 reference

12 December 2020

Effects of theophylline on breathlessness and exercise tolerance in patients with chronic airflow obstruction

1 reference

12 December 2020

Induction of suppressor T cells in asthmatic children by theophylline treatment

1 reference

12 December 2020

Physiologic effects of oral bronchodilators during rest and exercise in chronic obstructive pulmonary disease

1 reference

12 December 2020

The measurement of dyspnea. Contents, interobserver agreement, and physiologic correlates of two new clinical indexes

1 reference

12 December 2020

Accuracy of pulmonary function tests in predicting exercise tolerance in chronic obstructive pulmonary disease

1 reference

12 December 2020

Sustained-release theophylline reduces dyspnea in nonreversible obstructive airway disease

1 reference

12 December 2020

The efficacy of orally administered theophylline, inhaled salbutamol, and a combination of the two as chronic therapy in the management of chronic bronchitis with reversible air-flow obstruction

1 reference

12 December 2020

A new adaptable computerized system for the measurement of specific airways conductance

1 reference

12 December 2020

Identifiers

DOI

10.1136/THX.48.3.227

1 reference

release_i6bbjmpwbbdpbcm3tqlahwmvb4

13 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/i6bbjmpwbbdpbcm3tqlahwmvb4

24 November 2022

mapped directly with Wikidata item

1 reference

13 August 2017

PubMed publication ID

8497820

1 reference